Skip to content

The Challenge Of Biotech Investing Before, During And After COVID

“The premise here is simple: biotech investing is just as it was before COVID-19 and as it will be when the pandemic is finally over,” begins the author of today’s article. If one accepts this premise, what does that mean for investing in the three fronts of the war on the coronavirus (testing, treatment and vaccination)? For the author’s overview of each of these three areas – as well as the sole start-up biotech he is invested in right now – CLICK HERE.